These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35890416)

  • 21. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
    Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier-Free Nanomedicine for Cancer Immunotherapy.
    Fu Y; Bian X; Li P; Huang Y; Li C
    J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering nanomedicine for glutathione depletion-augmented cancer therapy.
    Xiong Y; Xiao C; Li Z; Yang X
    Chem Soc Rev; 2021 May; 50(10):6013-6041. PubMed ID: 34027953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine for Combination Urologic Cancer Immunotherapy.
    Tian Y; Liu Z; Wang J; Li L; Wang F; Zhu Z; Wang X
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
    Afzal M; Ameeduzzafar ; Alharbi KS; Alruwaili NK; Al-Abassi FA; Al-Malki AAL; Kazmi I; Kumar V; Kamal MA; Nadeem MS; Aslam M; Anwar F
    Semin Cancer Biol; 2021 Feb; 69():279-292. PubMed ID: 31870940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine and versatile therapies for cancer treatment.
    Shukla A; Maiti P
    MedComm (2020); 2022 Sep; 3(3):e163. PubMed ID: 35992969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic nanomedicine by combined gene and photothermal therapy.
    Kim J; Kim J; Jeong C; Kim WJ
    Adv Drug Deliv Rev; 2016 Mar; 98():99-112. PubMed ID: 26748259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced nanomedicines for the regulation of cancer metabolism.
    Yang J; Zhao Y; Zhou Y; Wei X; Wang H; Si N; Yang J; Zhao Q; Bian B; Zhao H
    Biomaterials; 2022 Jul; 286():121565. PubMed ID: 35576808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel nanomedicines to overcome cancer multidrug resistance.
    Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
    Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Black Phosphorus Nanosheet-Based Drug Delivery System for Synergistic Photodynamic/Photothermal/Chemotherapy of Cancer.
    Chen W; Ouyang J; Liu H; Chen M; Zeng K; Sheng J; Liu Z; Han Y; Wang L; Li J; Deng L; Liu YN; Guo S
    Adv Mater; 2017 Feb; 29(5):. PubMed ID: 27882622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimeric prodrug-based nanomedicines for cancer therapy.
    Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
    J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances of functional nanomaterials for cancer immunotherapeutic applications.
    Hao Y; Zhou X; Li R; Song Z; Min Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in Tumor-Associated Macrophages: From Bench to Bedside.
    Wang Y; Lin YX; Qiao SL; Wang J; Wang H
    Adv Biosyst; 2019 Feb; 3(2):e1800232. PubMed ID: 32627370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translational Multi-Disciplinary Approach for the Drug and Gene Delivery Systems for Cancer Treatment.
    Nayak R; Meerovich I; Dash AK
    AAPS PharmSciTech; 2019 Apr; 20(4):160. PubMed ID: 30968269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.